Relationships Between Body Composition and Cognitive Impairment in Hospitalised Middle-Aged Type 2 Diabetic Patients
© 2023 Li et al..
Objective: The aim of this study was to elucidate the relationship between specific body composition and the risk of Cognitive Impairment (CI) in middle-aged Type 2 Diabetes Mellitus (T2DM) patients.
Methods: This cross-sectional study included 504 hospitalized patients with T2DM from the Department of Endocrinology and Metabolism of the Tianjin Union Medical Center. Subjects were grouped by sex, and cognitive status was assessed using the Montreal Cognitive Assessment (MoCA). The relationship between body composition and cognitive ability was investigated with the use of linear regression analysis. The association between body composition and CI risk was determined by logistic regression analysis.
Results: The prevalence of CI was 39.3% in middle-aged T2DM patients. After adjusting for age, education, marriage status, carotid atherosclerosis, cerebrovascular disease and hemoglobin, multiple linear regression analysis showed that lean mass index (LMI), body mass index (BMI) and appendicular skeletal muscle index (SMI) were significant predictors for the MoCA scores in men (p < 0.05). In addition, BMI (OR 0.913, 95% CI 0.840-0.992) and LMI (OR 0.820, 95% CI 0.682-0.916) were independent protective factors for CI in males. After adjusted for age, education, marriage status, dietary control of diabetes and cerebrovascular disease, visceral obesity (VO, OR 1.950, 95% CI 1.033-3.684) and abdominal obesity (AO, OR 2.537, 95% CI 1.191-5.403) were risk factors for CI in female patients.
Conclusion: The results suggest that there may be different mechanisms underlying the relationship of body compositions and cognitive performance between middle-aged male and female patients with T2DM. In addition, our finding of potential determinants of cognitive impairment may facilitate the development of intervention programs for middle-aged type 2 diabetic patients. Nevertheless, more large prospective studies looking at cognition and changes in body composition over time are needed in the future to further support their association.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Diabetes, metabolic syndrome and obesity : targets and therapy - 16(2023) vom: 28., Seite 2389-2400 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Yao-Shuang [VerfasserIn] |
---|
Links: |
---|
Themen: |
Body composition |
---|
Anmerkungen: |
Date Revised 16.08.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2147/DMSO.S418111 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36080442X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM36080442X | ||
003 | DE-627 | ||
005 | 20231226083809.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2147/DMSO.S418111 |2 doi | |
028 | 5 | 2 | |a pubmed24n1202.xml |
035 | |a (DE-627)NLM36080442X | ||
035 | |a (NLM)37581116 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Yao-Shuang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Relationships Between Body Composition and Cognitive Impairment in Hospitalised Middle-Aged Type 2 Diabetic Patients |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 16.08.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 Li et al. | ||
520 | |a Objective: The aim of this study was to elucidate the relationship between specific body composition and the risk of Cognitive Impairment (CI) in middle-aged Type 2 Diabetes Mellitus (T2DM) patients | ||
520 | |a Methods: This cross-sectional study included 504 hospitalized patients with T2DM from the Department of Endocrinology and Metabolism of the Tianjin Union Medical Center. Subjects were grouped by sex, and cognitive status was assessed using the Montreal Cognitive Assessment (MoCA). The relationship between body composition and cognitive ability was investigated with the use of linear regression analysis. The association between body composition and CI risk was determined by logistic regression analysis | ||
520 | |a Results: The prevalence of CI was 39.3% in middle-aged T2DM patients. After adjusting for age, education, marriage status, carotid atherosclerosis, cerebrovascular disease and hemoglobin, multiple linear regression analysis showed that lean mass index (LMI), body mass index (BMI) and appendicular skeletal muscle index (SMI) were significant predictors for the MoCA scores in men (p < 0.05). In addition, BMI (OR 0.913, 95% CI 0.840-0.992) and LMI (OR 0.820, 95% CI 0.682-0.916) were independent protective factors for CI in males. After adjusted for age, education, marriage status, dietary control of diabetes and cerebrovascular disease, visceral obesity (VO, OR 1.950, 95% CI 1.033-3.684) and abdominal obesity (AO, OR 2.537, 95% CI 1.191-5.403) were risk factors for CI in female patients | ||
520 | |a Conclusion: The results suggest that there may be different mechanisms underlying the relationship of body compositions and cognitive performance between middle-aged male and female patients with T2DM. In addition, our finding of potential determinants of cognitive impairment may facilitate the development of intervention programs for middle-aged type 2 diabetic patients. Nevertheless, more large prospective studies looking at cognition and changes in body composition over time are needed in the future to further support their association | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a body composition | |
650 | 4 | |a cognitive impairment | |
650 | 4 | |a diabetes | |
650 | 4 | |a middle age | |
650 | 4 | |a sex | |
700 | 1 | |a Liu, Yan-Lan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jun-Jia |e verfasserin |4 aut | |
700 | 1 | |a Haghbin, Nahal |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xiao-He |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Wei-Ran |e verfasserin |4 aut | |
700 | 1 | |a Qiu, Hui-Na |e verfasserin |4 aut | |
700 | 1 | |a Xia, Long-Fei |e verfasserin |4 aut | |
700 | 1 | |a Wu, Fan |e verfasserin |4 aut | |
700 | 1 | |a Lin, Chen-Ying |e verfasserin |4 aut | |
700 | 1 | |a Li, Jing-Bo |e verfasserin |4 aut | |
700 | 1 | |a Lin, Jing-Na |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes, metabolic syndrome and obesity : targets and therapy |d 2008 |g 16(2023) vom: 28., Seite 2389-2400 |w (DE-627)NLM195025180 |x 1178-7007 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2023 |g day:28 |g pages:2389-2400 |
856 | 4 | 0 | |u http://dx.doi.org/10.2147/DMSO.S418111 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2023 |b 28 |h 2389-2400 |